.abstract img { width:300px !important; height:auto; display:block; text-align:center; margin-top:10px } .abstract { overflow-x:scroll } .abstract table { width:100%; display:block; border:hidden; border-collapse: collapse; margin-top:10px } .abstract td, th { border-top: 1px solid #ddd; padding: 4px 8px; } .abstract tbody tr:nth-child(even) td { background-color: #efefef; } .abstract a { overflow-wrap: break-word; word-wrap: break-word; }
A2922 - Mitochondrial Dysfunction Contributes to the Senescent Phenotype of IPF Lung Fibroblasts
Author Block: M. Schuliga1, D. W. Waters2, K. Blokland1, J. Jaffar3, G. P. Westall4, C. Prele5, S. E. Mutsaers6, J. K. Burgess7, C. Grainge1, D. A. Knight8; 1Hunter Medical Research Institute, Univ of Newcastle, Callaghan, Australia, 2The University of Newcastle, Newcastle, Australia, 3AIRMed, The Alfred Hospital, Melbourne, Australia, 4Alfred Hospital, Melbourne, Melbourne, Australia, 5Centre for Cell Therapy and Regenerative Medicine, University of Western Australia, Perth, Australia, 6Pathwest Laboratory Medicine Wa, Medlands 6009, Australia, 7Pathology and Medical Biology Section, University Medical Center Groningen, Groningen, Netherlands, 8Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia.
Rationale: Increasing evidence highlights that cellular senescence contributes to idiopathic pulmonary fibrosis (IPF). The DNA damage response (DDR) in senescence also leads to escalated mitochondrial superoxide production to reinforce senescence. This study characterises senescence in lung fibroblasts from IPF patients (IPF-LFs) and age-matched controls (Ctrl-LFs), delineating the role of mitochondria in senescence stabilization.
Methods: Fibroblast senescence was assessed using a composite set of markers, including p21 expression and senescence-associated-β-galactosidase activity, which were measured by PCR and cytochemical staining, respectively. The DDR was detected by formation of phosphorylated-p53 nuclear foci using immunofluorescence. A senescent-associated secretory phenotype (SASP) was characterised by measuring increases in cytokine production and inflammatory gene expression with ELISA and Nanostring technology, respectively. Mitochondrial dysfunction was monitored by increases in mitochondrial stress, mass and superoxide using the fluorogenic dyes, n-nonyl-acridine orange, Mitotracker Green and MitoSOX, respectively.
Results: Even at early passage, IPF-LFs were more senescent-like than Ctrl-LFs, exhibiting an intensified DDR, a SASP and mitochondrial dysfunction. The DNA damaging agent etoposide augmented senescence in Ctrl-LFs accompanied by heightened mitochondrial stress, mass and superoxide production. However, it had no effect on IPF-LFs. Mitochondrial perturbation by rotenone also evoked a DDR and senescence in Ctrl-LFs. Inhibition of mTORC1, a regulator of mitochondrial function or incubation with the antioxidant, N-acetyl cysteine attenuated pharmacological-induced senescence.
Conclusion: IPF-LFs exhibit senescent-like features and mitochondrial dysfunction reinforces the senescent phenotype. Understanding the mechanisms by which mitochondria contribute to fibroblast senescence in IPF has potentially important therapeutic implications.
Grant support: NHMRC research grant #1099569